Equities research analysts expect that AngioDynamics, Inc. (NASDAQ:ANGO) will post $0.20 earnings per share for the current quarter, according to Zacks Investment Research. Three analysts have issued estimates for AngioDynamics’ earnings, with estimates ranging from $0.19 to $0.20. AngioDynamics posted earnings per share of $0.19 in the same quarter last year, which would suggest a positive year-over-year growth rate of 5.3%. The company is scheduled to announce its next quarterly earnings report on Thursday, March 29th.
On average, analysts expect that AngioDynamics will report full year earnings of $0.72 per share for the current fiscal year, with EPS estimates ranging from $0.69 to $0.75. For the next year, analysts expect that the firm will post earnings of $0.89 per share, with EPS estimates ranging from $0.87 to $0.91. Zacks’ earnings per share averages are an average based on a survey of research firms that follow AngioDynamics.
AngioDynamics (NASDAQ:ANGO) last announced its quarterly earnings results on Thursday, January 4th. The medical instruments supplier reported $0.16 EPS for the quarter, hitting analysts’ consensus estimates of $0.16. The firm had revenue of $86.70 million during the quarter, compared to analyst estimates of $88.15 million. AngioDynamics had a negative net margin of 2.27% and a positive return on equity of 4.63%. The business’s revenue for the quarter was down 2.6% on a year-over-year basis. During the same period in the previous year, the business posted $0.19 earnings per share.
Hedge funds have recently bought and sold shares of the business. SG Americas Securities LLC bought a new position in AngioDynamics during the third quarter valued at $143,000. Trexquant Investment LP bought a new position in AngioDynamics during the third quarter valued at $175,000. Crossmark Global Holdings Inc. bought a new position in AngioDynamics during the fourth quarter valued at $172,000. Teachers Retirement System of The State of Kentucky increased its position in AngioDynamics by 54.9% during the second quarter. Teachers Retirement System of The State of Kentucky now owns 11,000 shares of the medical instruments supplier’s stock valued at $178,000 after acquiring an additional 3,900 shares during the last quarter. Finally, Teacher Retirement System of Texas bought a new position in AngioDynamics during the fourth quarter valued at $201,000. Institutional investors and hedge funds own 94.55% of the company’s stock.
Shares of AngioDynamics (NASDAQ:ANGO) traded up $0.12 during trading hours on Friday, reaching $16.54. 93,254 shares of the company’s stock traded hands, compared to its average volume of 264,401. The company has a debt-to-equity ratio of 0.17, a current ratio of 2.56 and a quick ratio of 1.65. AngioDynamics has a twelve month low of $14.80 and a twelve month high of $18.85. The stock has a market capitalization of $603.36, a P/E ratio of -78.76, a P/E/G ratio of 1.52 and a beta of 0.98.
AngioDynamics Company Profile
AngioDynamics, Inc designs, manufactures and sells a range of medical, surgical and diagnostic devices used by professional healthcare providers for vascular access, for the treatment of peripheral vascular disease and for use in oncology and surgical settings. The Company’s devices are used in minimally invasive, image-guided procedures.
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for AngioDynamics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for AngioDynamics and related companies with MarketBeat.com's FREE daily email newsletter.